Doctors must take into consideration no matter whether their clients with fundamental NAION danger aspects might be adversely impacted by use of PDE5 inhibitors. Individuals who have by now professional NAION are at increased chance of NAION recurrence. Hence, PDE5 inhibitors, which includes LEVITRA, need to be employed with caution in these client